Save 35% + Free Shipping — Single Vials In Stock · code

Back to Catalog

Peptides

Epitalon 10 mg

$95Per Unit

Ala-Glu-Asp-Gly synthetic tetrapeptide supplied with full analytical testing panel including HPLC and mass confirmation.

Lot EPI2026-04D · COA on request
Lyophilized tetrapeptide, sterile vial, 10 mg fill
2–8°C (stable 30 days)

5 × $95.00 = $475.00 $308.75 (35% off with code EHAB35 + free shipping)

Your order of 5 units qualifies: apply code EHAB35 at checkout for 35% off and free shipping.

Epitalon 10 mg

$308.75 for 5 · 35% off

Research use only
Epitalon 10 mg research packaging
Lyophilized tetrapeptide, sterile vial, 10 mg fill
Anubis Research Labs

Documentation

The certificate of analysis for the current lot (Lot EPI2026-04D) is sent on request, so you can review identity and purity testing before you order.

Request the lot COA

Research summary

Epitalon(Epithalon, Ala-Glu-Asp-Gly)

Regulatory status
Not approved in the U.S. FDA lists epitalon among substances that may present significant safety risks in compounding.
Strongest evidence
Animal studies, largely from its developers' group
Overview

Epitalon is a synthetic tetrapeptide developed in Russia in research on the pineal gland and aging.

What researchers study it for
  • Aging biology (animal models)
  • Tumor development in rodent models
Mechanism

Proposed effects on pineal function and gene regulation; not established in humans.

Evidence (3)
  1. Animal study

    HER-2/neu transgenic mice (Int J Cancer 2002)

    Inhibited development of spontaneous mammary tumors in a transgenic mouse model.[1]

  2. Animal study

    Colon carcinogenesis in rats (2003)

    Effects on proliferation and apoptosis in a rat colon-tumor model.[2]

  3. Review

    Peptides and ageing (2002)

    Review by the group that developed it.[3]

Limitations of the evidence
  • Human data are sparse and mostly not independently replicated.
  • Products on this site are sold for laboratory research only. They are not the medicines used in the trials above, and those results do not apply to research material.
Sources (4)
  1. 1.Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic miceAnisimov VN et al. Int J Cancer. 2002 Animal study
  2. 2.Epitalon and colon carcinogenesis in rats: proliferative activity and apoptosis in colon tumors and mucosaKossoy G et al. Int J Mol Med. 2003 Animal study
  3. 3.Peptides and AgeingKhavinson VKh. Neuro Endocrinol Lett. 2002 Review
  4. 4.Certain bulk drug substances for use in compounding that may present significant safety risks (lists epitalon)U.S. FDA, page current as of Apr 22, 2026 Regulatory
Every published studyPubMed search: epitalon OR epithalon(opens in a new tab)Every registered trialClinicalTrials.gov search: epitalon OR epithalon(opens in a new tab)

Reviewed 2026-10-02. Summaries describe published research and regulatory records; they are not medical advice and do not describe how to use this product. Sold for laboratory research use only.